Risk factors analysis of rebleeding of non-variceal upper gastrointestinal hemorrhage treated by gastrointestinal endoscopy
WU Lian-hui1 LUO Jia2 LIN Ming-fang2
1.Department of Digestive Endoscope,the First Hospital of Sanming City in Fujian Province,Sanming 365000,China;
2.Department of Gastroenterology,the First Hospital of Sanming City in Fujian Province,Sanming 365000,China
Abstract：ObjectiveTo analyze the risk factors of rebleeding of non－variceal upper gastrointestinal hemorrhage treated by gastrointestinal endoscopy.MethodsFrom February 2015 to February 2017,a total of 216 patients with non－variceal upper gastrointestinal bleeding who underwent endoscopic treatment in our hospital were selected as research objects.A-mong them,41 patients occurred with rebleeding and classified into the observation group,and the rest(n=175)without rebleeding was categorized into the control group.The basic data,examination indexes,and treatment process were recorded and compared.ResultsIn the observation group,the levels of hemoglobin and thrombocyte were both remarkably lower than those in the control group(P＜0.05).The percentage of vascular malformation,treatment time＞24 h,cardia tearing,hemorrhage of gradeⅠa,insufficiency of supportive treatment,hemorrhage due to malignant tumors and lack of following PPIs were all much higher than those in the control group (P＜0.05).Vascular malformation,Hemorrhage of gradeⅠa,cardia tearing and hemorrhage due to malignant tumors were all independent risk factors leading to rebleeding after gastrointestinal endoscopy(P＜0.01).ConclusionFor patients suffering from non－variceal upper gastrointestinal hemorrhage after gastrointestinal endoscopy,insufficiency of supportive treatment and low－level of hemochrome causes rebleeding.Besides,hemorrhage due to malignant tumor is also an important risk factor,which should be strengthened protection in time in order to ensure health of patients.
京公网安备 11010502046607号